Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

NCT01569659 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01569659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01569659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
July 31, 2015
Enrollment
101 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia